Soy Isoflavones for menopausal symptoms: B → B
Correction by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid-27327802].
What we said before vs now
Before
Grade B
After
Grade B
modest reduction in hot-flash frequency/severity; effect builds over weeks
What this does not change
- Interaction profile for Soy Isoflavones — unchanged unless there is a separate severity change.
- Dose guidance — unchanged unless the new evidence altered the studied dose range.
- Safety recommendations — unchanged unless a safety event is recorded separately.
Reviewer & methodology
Reviewed and signed by Substrate editorial (Independent research collective) on . Methodology v1.
See also
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Soy Isoflavones for menopausal symptoms: B → B. https://evidencebased.info/changes/2026-07-16-soyiso-menopause-b-to-b. Updated 2026-07-16.
BibTeX
@misc{substrate_6soyisomenopausebtob,
author = {Substrate editorial},
title = {Soy Isoflavones for menopausal symptoms: B → B},
year = {2026},
url = {https://evidencebased.info/changes/2026-07-16-soyiso-menopause-b-to-b},
note = {evidencebased.info}
}